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Abstract
Introduction: As MEDLINE indexers tag similar articles as duplicates even when journals have not addressed the duplication(s), we sought to de-
termine the reasons behind the tagged duplications, and if the journals had undertaken or had planned to undertake any actions to address them.   
Materials and methods: On 16 January 2013, we extracted all tagged duplicate publications (DPs), analysed published notices, and then contac-
ted MEDLINE and editors regarding cases unaddressed by notices. For non-respondents, we compared full text of the articles. We followed up the 
study for the next 5 years to see if any changes occurred. 
Results: We found 1011 indexed DPs, which represented 555 possible DP cases (in MEDLINE, both the original and the duplicate are assigned a DP 
tag). Six cases were excluded as we could not obtain their full text. Additional 190 (35%) cases were incorrectly tagged as DPs. Of 359 actual cases 
of DPs, 200 (54%) were due to publishers’ actions (e.g. identical publications in the same journal), and 159 (46%) due to authors’ actions (e.g. article 
submission to more than one journal). Of the 359 cases, 185 (52%) were addressed by notices, but only 25 (7%) retracted. Following our notificati-
ons, MEDLINE corrected 138 (73%) incorrectly tagged cases, and editors retracted 8 articles.
Conclusions: Despite clear policies on how to handle DPs, just half (54%) of the DPs in MEDLINE were addressed by journals and only 9% retracted. 
Publishers, editors, and indexers need to develop and implement standards for better correction of duplicate published records.
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Introduction
Duplicate publication (DP) is a publication that 
substantially overlaps with one already published, 
but does not appropriately acknowledge its 
source (1). This practice can inflate an author’s or 
journal’s prestige, but wastes time and resources 
of readers, peer reviewers, and publishers (2,3). 
Duplication of data can also lead to biased esti-
mates of efficacy or safety of treatments and prod-
ucts in meta-analyses of health interventions, as 
the same data which is calculated twice exagger-
ates the accuracy of the analysis, and leaves an im-
pression that more patients were involved in test-
ing a drug (4,5). Not referencing the origin or the 
Electronic supplementary material available online for this article.
overlap of the data, can therefore be considered 
akin to fabrication, as it implies the data or infor-
mation is new, when in fact it is not. For these rea-
sons, all major international editorial organiza-
tions, including the Committee on Publication 
Ethics (COPE), the Council of Science Editors (CSE), 
and the International Committee of Medical Jour-
nal Editors (ICMJE), recommend retracting DPs 
(1,6,7). A 2014 study of MEDLINE retractions 
showed that duplication accounted for 22% (506 
out of 2343) of retracted publications (8). Retract-
ed publications in MEDLINE are tagged following 
the formal issuance of retraction by an authorized 
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party (e.g. author or a journal). Duplicate publica-
tions, however, are tagged whenever substantial 
overlap between two or more articles is discov-
ered during indexing, irrespective of an author-
ized notification (9,10).  Furthermore, the DP [Publi-
cation Type] tag is given to both the duplicate(s) 
and to the original article(s). Indexers, however, do 
not routinely examine articles for originality, so 
the tagged DPs do not necessarily include all in-
stances of DPs in MEDLINE (10).
The aim of our study was to investigate DPs in-
dexed in MEDLINE, specifically whether they were 
retracted or corrected by journals, how visible 
those corrections were on the journals’ websites, 
and whether there was a change in DP citation 
counts after the publication of notices of duplica-
tion. Following the presentation of our initial find-
ings at the Congress on Peer Review and Biomedi-
cal Publication in September 2013, we contacted 
National Library of Medicine (NLM) regarding pos-
sible indexing errors, and journal editors regard-
ing unaddressed suspected duplications. Follow-
ing their replies, for still unresolved cases we com-
pared the full texts of DPs to confirm if they were 
indeed duplicate.
Materials and methods 
On 16 January 2013, we extracted all citations in-
dexed as duplicate publications [Publication Type] 
in PubMed and created a database using the Pub-
Med2XL© software (11). We matched all extracted 
citations (N = 1011) by analysing the similarity in 
their titles, abstracts and authors in order to estab-
lish the number of cases of possible DPs. This re-
vealed that among the 1011 citations extracted, 
there were 9 notices of duplicate publications and 
1 letter to the editor that were (incorrectly) tagged 
as NLM tags notices of duplicate publications as a 
[Publication Type] Comment and with a Medical 
Subject Heading (MeSH) term Duplicate publica-
tion as a topic. Of 9 notices incorrectly tagged, 6 
mentioned cases whose manuscripts were not 
tagged with the DP tag in MEDLINE, while 3 re-
ferred to cases whose manuscripts were also 
tagged. The letter to the editor described a case in 
which the authors realized during article proofing 
that a part of the study was already published and 
alerted the editors about it (12). 
Of the remaining 1001 citations, 145 were citations 
with no similar articles tagged as DPs, while 856 
could be matched with others and amounted to 
400 possible cases of DPs. To determine if all were 
indeed DP cases, we investigated whether they 
had been acknowledged by the journal(s), by 
checking all linkages to the articles visible in MED-
LINE or on the article’s website and obtaining the 
full texts of found notices. We then checked 
whether notices included the full title of the dupli-
cate article in their heading, listed the reason be-
hind the duplication, and were visible and freely 
accessible on the journal’s website, as recom-
mended by the ICMJE and COPE (1,6). We also 
checked if the notices mentioned contacting the 
authors or included the authors’ explanation for 
the duplication. For the purpose of this study, the 
article that was published first was designated as 
original and the subsequent publication(s) as 
duplicate(s), unless otherwise stated in the pub-
lished notice(s). Additionally, we classified the DPs 
as retracted if the notice was titled as retraction, or 
its wording mentioned the article was withdrawn, 
retracted or removed. Based on MEDLINE or jour-
nal online record we then extracted the following 
data: 1) the time (in months) from the original pub-
lication to duplicate publication, 2) the time (in 
months) from the duplicate publication to the 
publication of the notice, and 3) the difference in 
author by-line order between the original and du-
plicate publication. We also checked the citation 
records of DPs in the Web of Science (WoS) in May 
2014. As per previous research, to allow for publi-
cation processing time and visibility of notices to 
reach the research community, we also separately 
collected citations that occurred two years after 
the publication of a notice (13). 
Additionally, we informed NLM of possible index-
ing errors and contacted journal editors on 6-8 
May 2015 regarding suspected unaddressed dupli-
cations for 250 possible cases of DPs, as no emails 
were available for 16 cases (template letter to the 
editors is available in Supplementary material). We 
sent personalised emails to editors and asked 
them if they were aware that the articles were 
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tagged as DPs or that NLM was tagging publica-
tions as duplicate irrespective of official notices by 
journal(s). We received replies for 181 of 250 cases 
(72%).
For cases we did not receive the reply (following 
two reminders on 1-2 September and 28 October 
2015, N = 69); for cases editors said they would in-
vestigate and forward us their findings, but never 
did so, even a year after we contacted them (N = 
28); for cases editors did not specify what they 
would do (N = 7); for cases where editors said the 
other journal had a publication with a later date so 
they should investigate (N = 5), as well as for cases 
we couldn’t contact the editors by e-mail (N = 16) 
as journals ceased publishing or no contact was 
listed, we obtained the full text of the articles in 
question, and determined if they were indeed du-
plicates by manually comparing their text similari-
ty and possible intentional republication (declara-
tion or citation of the original article). For 6 cases 
we were unable to obtain the full text versions of 
articles or obtain the answers from editors, and so 
we excluded them from the analysis. In total, we 
manually compared 119 cases of possible DPs. Fi-
nally, we rechecked during May 2017 and again in 
June 2018, if the editors or NLM took any further 
actions regarding the cases we alerted them too. 
The database with raw data is available from the 
authors (excluding the correspondence and con-
tact information of editors in order to protect the 
anonymity of responses).
Statistical analysis
Data were presented as frequencies for categorical 
variables, and, depending on the distribution of 
data, means or medians with 95% confidence in-
tervals (CI) for continuous variables. Differences 
between citation counts of original and duplicate 
publications were tested by Wilcoxon test, while 
the equal distributions of inclusion of authors’ re-
sponses within the published notices was tested 
with a chi-squared test. All analyses were conduct-
ed using MedCalc v.12.5 (MedCalc, Ostend, Bel-
gium). All calculations were done on DP cases for 
which MEDLINE assigned the DP tag to at least 
one article. This means that we did not include 6 
DP notices incorrectly tagged as DPs, as our goal 
was to follow up on papers tagged by NLM and 
the analysis of notices as sources of DPs would go 
beyond the scope of this research, and had been 
previously reported (8). 
Results
On 16 January 2013, there were 1011 citations in-
dexed (with a DP [Publication Type] tag) in MED-
LINE amounting to 555 possible cases of different 
DPs (as MEDLINE indexes both the original and 
duplicate(s) article(s) with the DP tags). Following 
the analysis of published notices, communication 
with editors and comparison of full text of cita-
tions, we were able to analyse 549 cases (for 6 we 
were unable to retrieve full texts or receive a re-
sponse from editors).
Out of 549 analysed cases, 359 (65%) were cases of 
DP while 190 (35%) were cases incorrectly indexed 
as duplicates. The majority of the duplicates (N = 
200; 56%) occurred due to the publishers’ actions, 
most commonly publication of the same article in 
two different issues of the same journal, while 
those occurring due to authors’ actions (N = 159; 
44%) occurred most commonly due to submission 
of the same manuscript to two different journals 
(Table 1).
Cases incorrectly indexed were most commonly 
intentional republications, and until 4 June 2018 
NLM had corrected 138 (73%) of them (Table 2). 
Duplicate publications tags were not visible in de-
fault PubMed search result output. This informa-
tion was visible only after expanding the “Supple-
mental information” field (Supplementary material 
Figures S1-2). Additionally, of the 181 (72%) of 250 
cases for which we got the response from the edi-
tors, only 1 (1%) editor confirmed being aware of 
the DP tagging in MEDLINE, 166 (92%) did not ex-
plicitly confirm or deny it, but opened an investi-
gation of the issue after we had contacted them, 
and one (1%) asked to acknowledge us for alerting 
them of the DP. Fifteen editors (8%) explicitly stat-
ed they were not aware of the practice. 
Out of 359 cases of DPs, 185 (51%) had a published 
notice (included is a case of triplicate duplication, 
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Duplications due to





Author’s actions: 120 (62) 39 (24) 159 (44)
Submission to multiple journals 75 (39) 34 (21) 109 (30)
Study fragmentation 30 (15) 3 (2) 33 (9)
Submission without co-author(s) approval 12 (6) 0 (0) 12 (3)
Plagiarism 1 (1) 2 (1) 3 (1)
Pharmaceutical company sent the same database to two different 
teams for write-up 1 (1) 0 (0) 1 (0)
Authors lost communication with the journal following prolonged 
article processing 1 (1) 0 (0) 1 (0)
Publisher’s actions: 74 (38) 126 (76) 200 (56)
Article published twice in different volumes 62 (32) 45 (27) 107 (30)
Double publication in sister journals or agreement between the 
journals without citing the original 2 (1) 62 (38) 64 (18)
Article published twice in the same volume 6 (3) 15 (9) 21 (6)
Wrong indexation sent to MEDLINE 0 (0) 4 (2) 4 (1)
Journal’s oversight of authors declaration of secondary submission/
redaction error 4 (2) 0 (0) 4 (1)
Total 194 (54) 165 (46) 359 (100)
Type of article Articles, N (%) Articles corrected by NLM until 24 June 2018, N (%)
Republished or translated articles citing the original† 51 (27) 34 (67)
Simultaneous publications (e.g. guidelines, editorials) 50 (26) 36 (72)
Articles with no obvious reasons for DP indexation‡ 30 (16) 30 (100)
Similar papers (e.g. study fragmentation, expanded reviews) 17 (9) 4 (23)
Articles from the International Journal of Biostatistics 12 (6) 12 (100)
Notices of duplicate publication† 9 (5) 9 (100)
Article updates† 8 (4) 6 (75)
Articles on controlled ecological life support system 7 (4) 7 (100)
Articles with supplements indexed separately 4 (2) 0 (0)
Letter to editor that prevents duplication 1 (1) 0 (0)
Comment and a reply to the comment 1 (1) 0 (0)
Total 190 (100) 138 (73)
†NLM Fact Sheet specifically states that article reprints, updates and notices of duplication are not indexed as DPs, but have their 
own separate indexation (10). ‡After searching MEDLINE using authors’ names and title keywords we found no similar articles. NLM 
removed the DP tag after we contacted them. NLM - National Library of Medicine. DP - duplicate publications. 
Table 1. Reasons for duplicate publications indexed in MEDLINE
Table 2. Cases incorrectly indexed as duplicate publications in MEDLINE
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even though the notice only addresses the dupli-
cation). Almost two thirds of published notices 
(117 of 185, 63%, χ2 = 12.454, df = 1, P < 0.001) re-
ported author’s actions as the reason for the dupli-
cation (Table 1). Of the 185 notices, 174 (94%) were 
visible in PubMed and designated most common-
ly as comments (N = 103; 56%) or errata (N = 54; 
29%) (Table 3). 
Notices were visible (clearly linked to the article) 
on the article’s website for only 48 (26%) DPs, while 
for 4 (2%) they were visible as part of PubMed Cen-
tral (PMC) records. In 11 (6%) cases journals did not 
have the article indexed online, while for the rest 
(N = 122; 66%) the notices were not visible. The ti-
tles of published notices varied in their format of 
which the most common was a general notifica-
tion (N = 119; 64%) (Table 4). 
The full text of the notices was mostly freely avail-
able (N = 141; 76%). For 29 (16%) it was restricted 
behind pay-walls, while for 9 (5%) the notice, and 
for 6 (3%) the whole volume containing the notice, 
were not available online. Half of the notices that 
cited authors’ errors as the reasons for duplication 
(66 out of 117, 56%, χ2 = 1.675, df = 1, P = 0.196) in-
cluded a statement or acknowledgment from the 
authors. 
Only 25 (7%) of 359 DP cases were retracted. Of 
the 25, 13 (52%) had a “Retraction in” designation 
in MEDLINE, 5 (20%) were marked as having errata, 
3 (12%) as having comments, and 4 (16%) had no 
visible notice (Table 3). On the journals’ webpages, 
10 articles (40%) were marked as retracted, 12 
(48%) had no visible notification, and for 3 (12%) 
the journal’s webpage did not have the volume 
online. Half of the retractions occurred due to au-
thor’s (N = 13; 52%) and half due to publisher’s ac-
tions (N = 12; 48%).
Following our contact with the editors, additional 
9 notices were published: 8 retractions, of which 6 
for publishers’ errors and 2 for authors’ errors, and 
1 notice of redundant publication (author’s error). 
Furthermore, 3 online versions of articles were up-
dated to include a statement that an article was a 
peer reviewed version of a manuscript submitted 
to a conference. For additional 38 cases, editors 
said they would publish a notice, but have not 
done so even after a year, and for 11 cases editors 
specified they would not publish a notice (Supple-
mentary material Table S1).
The earliest DP was published in 1980, and the first 
retracted in 1990. On average, there were 11 DPs 
per year (95% CI: 7 - 14), with a peak of 28 in 2004 
(Supplementary material Figure S3-4). Overall me-
dian time from the original to duplicate publication 
was 3 months (95% CI: 2 - 3), and from the DP to the 
notice of duplication (or retraction) 8 months (95% 
CI: 6 - 10). The median number of total citations for 
original and duplicate articles was 6 (95% CI: 5 - 7); 
and the median average citation by year 0.5 (95% 
CI: 0.4 - 0.6). Hundred and ten (16%) of the 691 arti-
Comment or Correction type Retracted DP, N (%) Non-retracted DP, N (%) Total, N (%)
Comment in 3 (12) 102 (64) 105 (56)
Erratum in 5 (20) 49 (31) 54 (29)
Retraction in 13 (52) 0 (0) 13 (7)
Comment on 0 (0) 1 (1) 1 (1)
Corrected and republished from 0 (0) 1 (1) 1 (1)
Not visible in MEDLINE* 4 (16) 7 (4) 11 (6)
Total 25 (14) 160 (86) 185 (100)
*The published notice was either visible on the journal’s website or we were informed by the editor of its existence, but the notice 
was not linked to the article in MEDLINE. DP - duplicate publications.
Table 3. Type of comments/corrections visible in MEDLINE to alert users about duplicate publications
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Heading type Retracted DP, N (%)
Non-retracted DP, 
N (%) Total, N (%)
General notification: 15 (60) 104 (65) 119 (64)
A statement of retractions 3 (12) 0 (0) 3 (2)
Correction(s) 1 (4) 10 (6) 11 (6)
Correction: Notice of redundant publication 0 (0) 4 (3) 4 (2)
Corrigendum 0 (0) 2 (1) 2 (1)
Department of error 0 (0) 1 (1) 1 (1)
Duplicate/dual publication 0 (0) 13 (8) 13 (7)
Duplicate submission and publication of correspondence 0 (0) 1 (1) 1 (1)
Editorial 0 (0) 2 (1) 2 (1)
Editor(-s/-ial) or publisher’s note/announcement/comment/statement 1 (4) 7 (4) 8 (4)
Erratum(-a) 2 (8) 16 (10) 18 (10)
Erratum: (double publication/notice of redundant publication) 0 (0) 2 (1) 2 (1)
Letter to the editors 0 (0) 2 (1) 2 (1)
Notice (to readers) 0 (0) 4 (3) 4 (2)
Notice of (inadvertent) duplicate/dual publication 1 (4) 29 (18) 30 (16)
Notice of redundant publication 1 (4) 8 (5) 9 (5)
Retraction (notice/ of publication) 5 (20) 0 (0) 5 (3)
Scientific publications: ethical issues or fraud 0 (0) 1 (1) 1 (1)
Statement of duplicate publication 0 (0) 1 (1) 1 (1)
Table of contents notification 0 (0) 1 (1) 1 (1)
Table of contents: Retraction 1 (4) 0 (0) 1 (1)
Notification with the full title of the DP 
(e.g. “Notice of duplicate submission: Use of the superficial femoral 
vein as a replacement for large veins”)
6 (24) 15 (9) 23 (12)
Only the full title of the DP 0 (0) 16 (9) 13 (7)
Notification with the DP title and reference
(e.g. “Notice of duplicate publication: The use of mitomycin-C 
for respiratory papillomas. Clinical, histologic and biochemical 
correlation. Saudi Med J 2005;26:1737-45”)
4 (16) 9 (6) 13 (7)
DP reference only
(e.g. “Transfusion 1998;38:79-85”) 0 (0) 8 (5) 8 (4)
Notification with the DP reference
(e.g. “Notice of Redundant Publication: Am J Kidney Dis. 
2010;55:639-47”)
0 (0) 8 (5) 8 (4)
DP title and reference only
(e.g. “Exercise induced anaphylaxis and pregnancy. Anaesthesia 
2007;62:420.”)
0 (0) 1 (1) 1 (1)
Total 25 (100) 160 (100) 185 (100)
The published notice was either visible on the journal’s website or we were informed by the editor of its existence, but the notice 
was not linked to the article in MEDLINE. DP - duplicate publications.
Table 4. Headings of notifications publishers’ use to alert readers of duplicate publications
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cles indexed as DP were never cited (the total of 
691 articles is based on counting all original, dupli-
cate and triplicate citations indexed and having a 
DP tag). There were no differences between the to-
tal citation count and the average citation per year 
between the duplicates and their corresponding 
original articles (P = 0.125 and P = 0.438, respective-
ly; Supplementary material Table S2). Separate 
analysis of duplicates with published notices also 
yielded no differences between their total citation 
counts (P = 0.106), average citation per year (P = 
0.259) or citations that occurred two years follow-
ing publication of the duplication notice (P = 0.835) 
(Supplementary material Table S2). In cases of du-
plications that occurred due to the publisher’s ac-
tions (N = 200), the number of authors and the by-
line order of DPs and original articles were in 93% 
(N = 185) of the cases identical; while for DPs occur-
ring due to author’s actions (N = 159) they were 
identical in 43% (N = 68) of the cases (Supplemen-
tary material Table S3).
Discussion
Our study demonstrated that, despite the exist-
ence of clear guidelines on how to deal with dupli-
cate publications, almost half of the DPs (46%) 
tagged in MEDLINE have not been addressed by 
journals and only 9% were adequately addressed, 
i.e. rectracted (1,6,7).
While our study was not designed to look at the 
reasons for the lack of adherence to editorial poli-
cies, previous studies have reported on the unwill-
ingness and difficulties in addressing misconduct 
and errors (e.g. contact ambiguity, (in)appropriate 
timeliness, inability to obtain raw data), and the in-
consistencies of implementing misconduct poli-
cies in biomedical journals, and scientific commu-
nities (14,15,17-20). It is also possible that DPs do 
not invoke the same reaction as claims of fabricat-
ed or falsified data. In our study, we did not receive 
any response from the journals for 28% (69 of 250) 
of enquiries. Additionally, the 38 editors who said 
they would address the DPs have not done so 
within a year of being contacted. 
The limitation of our study was the fact that we 
communicated with listed contact persons of the 
journals, so we may have not reached some of the 
editors, as was previously reported by researchers 
handling scientific misconduct (16). Furthermore, 
our sample was based only on articles tagged as 
duplicates by the NLM indexing staff, and they 
most likely represent only a portion of all DP cases 
in MEDLINE as 6 of 9 notices that were incorrectly 
tagged as DPs in our sample mentioned addition-
al cases of DPs, and a study of 2343 retracted arti-
cles in MEDLINE which found 506 retractions were 
due to DPs, had only 16 of publications overlap-
ping with ours (8,21). We tried contacting the au-
thors of the study to compare our datasets and 
determine the combined number of DPs, but re-
ceived no replies. As many journals still do not rou-
tinely check article similarity upon submission, 
and those that do so are often unable to compare 
them to all existing publications due to differences 
in indexing and coverage of most common simi-
larity check services, the number of DPs could be 
even larger. 
Our study also showed that, similar to retracted 
publications, DPs continued to be cited even after 
journals published notices of duplication (22-25). 
The likely reasons behind this are the following: 1) 
the DP indexation is not easily visible (example in 
S1 Figures 1-3); 2) editors use a wide range of no-
tices to alert users of DPs (Table 4); 3) papers are 
often cited based only on read abstracts or taken 
from lists of references of other authors; 4) pub-
lishers’ website are rarely used to access articles 
(where the notice of DP may exist); and 5) current 
reference management software (e.g. EndNote, 
Zotero) do not alert users of subsequent notices, 
errata and retractions, which leaves researchers 
unaware of changes following publication of a pa-
per (26-29). 
Based on the negative impact duplicate publica-
tions have on meta-analyses, the time spent on ex-
cluding duplicates when conducting systematic 
reviews, and problems in correcting duplicates as 
demonstrated in our study; bibliographical data-
bases, journals and publishers should increase 
their efforts to clearly mark retracted and dupli-
cate publications (perhaps by adding an addition-
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al field alongside the title of DP, such as Web of Sci-
ence practice for retracted publications), as well as 
to clearly identify the final versions of papers 
(4,5,30-32). Furthermore, as has already been sug-
gested, tools could be developed to alert users of 
changes to papers they previously cited (24).
Finally, as indexing in bibliographic databases can 
result in errors, (35% incorrectly indexed articles in 
our study), as the online versions are often not up-
dated (only 24% of notices were visible on the 
journal’s website in our study), and as there are 
currently no legislative ways to ensure proper han-
dling of corrections or versioning or articles; it is 
perhaps time to consider partial or complete col-
laborative volunteering of the public and research-
ers, or use of machine learning algorithms, for tag-
ging and classifying of scientific records (33-38). 
Additionally, scientific publishing should perhaps 
adopt to a more ‘living’ and user-friendly versions 
of articles in which editing is made easier after the 
original publication, e.g. Wiki content pages (and 
content management system) or Clinicaltrials.gov 
archive site records, which showcase updated ver-
sions, but keep a record of all changes that oc-
curred (36,39). Such ‘living’ and interactive articles 
could also solve the problem of the invisibility and 
discrepancy in the usage and titles of notices, er-
rata, comments, corrigenda, reprints and retrac-
tions, as reported previously and confirmed in our 
study (34,35,40-42).
The two main categories we used to classify DPs, 
the authors’ and the publishers’ actions, invoke a 
question whether publishers’ actions should be 
retracted. Unlike author’s actions, they rarely con-
tain changes in the author by-line order of two 
publications, nor otherwise indicate deliberate ac-
tions so a simple erratum that would add the des-
ignation of a reprint, or an updated version of the 
article could remedy the situation (21,40). As au-
thors’ actions leading to DPs constitute detrimen-
tal research practice, a clear distinction between 
the two DP types should be made.
Our study has also shown that the number of arti-
cles tagged as DPs in MEDLINE has been decreas-
ing in the last several years, which may reflect a 
positive change in the publishing culture, where a 
submission of a same article to more than one 
journal is now widely considered unacceptable 
and wasteful. However, with no visible transparen-
cy of how many indexers detect or report DPs, and 
clear indication from NLM that they do not regu-
larly check for duplications, the DPs tagged in 
MEDLINE may not reflect the actual number of 
bio medical DPs. 
Our finding that almost a half of DPs remain unad-
dressed by journals and that many editors have 
failed to address the DPs in a reasonable time after 
we informed them of their existence, raise a ques-
tion should these (in)actions be considered edito-
rial misconduct and who should policy them or 
alert the readers or authors of such fallacies. Fur-
thermore, what should be done for DPs that may 
be discovered in the future when more and more 
of old journal issues will be retroactively indexed 
in bibliographic databases? Should a moratorium 
be placed on scientific misconduct, as some sug-
gest, or should duplicates be addressed by COPE, 
editorial organizations or bibliographic databases 
themselves, even when the journals in question 
are no longer publishing or the authors can no 
longer be contacted (43). After all, while investigat-
ing scientific misconduct requires a lot of time and 
effort, a comparison of two (or more) similar pub-
lished records is a more straightforward task.
In conclusion, taking into consideration the cur-
rent situation with DP indexing and the digital 
tools available, there is a need for concrete actions 
of stakeholders to ensure that duplicate publica-
tions are identified, mapped and the reasons be-
hind the duplications resolved in a prompt and 
transparent way across all scientific fields.
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